1 Center for Multiple Sclerosis and Autoimmune Neurology, Department of Neurology, Mayo Clinic College of Medicine, Rochester, Minnesota.
2 Queen Square Multiple Sclerosis Centre, UCL Institute of Neurology, Faculty of Brain Sciences, University College London, London, United Kingdom.
3 Great Ormond Street Hospital, University College London, London, United Kingdom.
4 Department of Neurology, Children's Healthcare of Atlanta, Emory University School of Medicine, Atlanta, Georgia.
5 Service de Neurologie, Sclérose en Plaques, Pathologies de la Myéline et Neuro-Inflammation, Hôpital Neurologique Pierre Wertheimer, Hospices Civils de Lyon, Lyon, France.
6 Centre de Référence des Maladies Inflammatoires Rares du Cerveau et de la Moelle, Hôpital Neurologique Pierre Wertheimer, Hospices Civils de Lyon, Lyon, France.
7 Department of Neurology, University Hospital of Rennes, Rennes, France.
8 Department of Neurology, University Hospital of Marseille, Marseille, France.
9 Department of Neurology, Université de Rouen Normandie, Rouen, France.
10 Department of Neurology, University Hospital of Toulouse, Toulouse, France.
11 Department of Ophthalmology, Mayo Clinic College of Medicine, Rochester, Minnesota.
12 Department of Laboratory Medicine and Pathology, Mayo Clinic College of Medicine, Rochester, Minnesota.
13 Division of Neurology, Department of Medicine, National University Health System, Singapore.
This international multicenter study seeks to determine the frequency and characteristics of meningitis in myelin oligodendrocyte glycoprotein antibody (MOGAD)–associated disease and highlight its pathology.